Investor suitability

For those who:

  • want to invest in health sciences companies
  • are investing for the medium and/or long term
  • can tolerate medium to high risk

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.


Fund/ETF Facts (2023-08-31)

Inception date

2000-08-08

Asset class

Sector Equity

Income distribution

Quarterly

Minimum investment

$500 initial/$25 additional

Growth of $10,000


CI Prestige Pricing – Automatic discounted pricing

CI Prestige Pricing fee reductions apply to management fees and start at $100,000.

Investment amount Net Management Fee
$100,000 and above 0.875%
$500,000 and above 0.840%
$1,000,000 and above 0.780%
$2,500,000 and above 0.700%
$5,000,000 and above 0.580%

Please refer to Simplified Prospectus Part A for more details on CI Prestige Pricing